| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 01/04/1995 | EP0631624A1 Receptor complexes with b29 (ig-beta or ig-gamma) and their uses |
| 01/04/1995 | EP0631619A1 Reconstituted cartilage tissue |
| 01/04/1995 | EP0631618A1 Culturing of hematopoietic stem cells and their genetic engineering |
| 01/04/1995 | EP0631616A1 Fatty acid microspheres containing enterococcus for use to enhance growth and improve carcass quality |
| 01/04/1995 | CN1096954A Anti-senility medicine made of compound amino-acids and trace elements |
| 01/04/1995 | CN1096953A Traditional Chinese medicine for curing osteoporosis |
| 01/03/1995 | US5378811 Pure C3b inactivator and a process for producing said protein |
| 01/03/1995 | US5378687 Use of human blood coagulation factor XIII for the treatment of ulcerative colitis |
| 01/03/1995 | US5378601 Method of preserving platelets with apyrase and an antioxidant |
| 01/03/1995 | US5378463 Bactericide, biosynthesis |
| 01/03/1995 | US5378461 Balsam mixture of a benzoquinone with vitamins A, E, and D carried by squalene or squalane |
| 01/03/1995 | US5378459 Treatment of Streptococcus microorganisms |
| 01/02/1995 | CA2126537A1 Mineral ion solution, anti-human immunodeficiency virus agent, and aids-treating agent |
| 12/28/1994 | EP0630409A1 Defective packaging non-oncoviral vectors based on mpmv and hiv |
| 12/28/1994 | EP0630275A1 Fibrin sealant delivery method |
| 12/28/1994 | EP0630257A1 Immune-enhancing agent for therapeutic use in immunocompromised hosts |
| 12/28/1994 | CN1096680A Medicine for treating crebrovascular disease |
| 12/28/1994 | CN1096678A Medicine for treating pustula maligna and scald |
| 12/28/1994 | CN1096654A Health natural beverage |
| 12/27/1994 | US5376678 Active principle based on avermectins, related strain and process for the preparation thereof, as well as veterinary compositions containing it |
| 12/27/1994 | US5376379 Liposomes of thermal waters stabilized in a DNA gel |
| 12/22/1994 | WO1994029471A1 Adenoviral vectors for treatment of hemophilia |
| 12/22/1994 | WO1994029470A1 Retroviral vectors for transducing beta-globin gene and beta-locus control region derivatives |
| 12/22/1994 | WO1994029438A1 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
| 12/22/1994 | WO1994029436A1 Methods for selectively stimulating proliferation of t cells |
| 12/22/1994 | WO1994029333A1 Immunoreactive reagents employing monoamine oxidase |
| 12/22/1994 | WO1994028950A1 Plasma-like solution |
| 12/22/1994 | WO1994028938A1 Adenovirus vectors for gene therapy sponsorship |
| 12/22/1994 | WO1994028934A1 Adoptive immune reconstitution treatment for patients with acquired immunodeficiencies |
| 12/22/1994 | WO1994028928A1 Novel attenuated pseudomonas aeruginosa strains |
| 12/22/1994 | WO1994028922A1 Treatment of neuromuscular disorders and conditions with different botulinum serotype |
| 12/22/1994 | WO1994016074A3 High molecular weight b-cell growth factor: interleukin-14 |
| 12/22/1994 | DE4401419C1 Secretion of proteins of the outer membrane of Gram-negative bacteria by means of Gram-positive host organisms |
| 12/22/1994 | CA2164953A1 Retroviral vectors for transducing beta-globin gene and beta-locus control region derivatives |
| 12/22/1994 | CA2164518A1 Immunoreactive reagents employing monoamine oxidase |
| 12/22/1994 | CA2162497A1 Adenoviral vectors for treatment of hemophilia |
| 12/21/1994 | EP0629703A2 Monoclonal antibodies to Fc receptors for immunoglobulin G on human mono-nuclear phagocytes, bifunctional antibodies, target specific effector cells, targeted macrophages, and innunoassays |
| 12/21/1994 | EP0629293A1 Assay for adrenal autoantigen |
| 12/21/1994 | EP0629130A1 Use of interleukin-10 to suppress graft-vs.-host disease |
| 12/21/1994 | EP0629129A1 Method for kidney tubulogenesis |
| 12/21/1994 | CN1096584A Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of hla-c-clone 10/mage-1 derived peptides, and method for treating said......... |
| 12/21/1994 | CN1096456A Medicine for treating systemic lupus erythematosus and producing method thereof |
| 12/21/1994 | CN1096448A Burn and scald drug |
| 12/21/1994 | CN1096444A Lucid ganoderma-pollen liquor |
| 12/20/1994 | US5374618 Calcitonin peptides, and gene related pharmaceutical compositions |
| 12/20/1994 | US5374549 Treating tumors; culturing with suppression of expansion of adherent lymphokine-activated killer(A-LAK) cells |
| 12/20/1994 | US5374515 Tissue culture system |
| 12/20/1994 | CA1333565C Process for the preparation of highly stable, soft gelatine capsules for therapeutical purposes |
| 12/20/1994 | CA1333564C Treatment of gastro-intestinal disorders |
| 12/20/1994 | CA1333562C Preservation of viruses |
| 12/14/1994 | EP0628074A1 $i(IN VITRO) ACTIVATION OF CYTOTOXIC T CELLS |
| 12/14/1994 | EP0628056A1 Directed human immune globulin for the prevention and treatment of staphylococcal infections |
| 12/14/1994 | EP0627924A1 Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer |
| 12/14/1994 | EP0627918A1 New use of omega-3-fatty acids |
| 12/14/1994 | EP0627917A1 Cytoprotective compositions containing pyruvate and antioxidants |
| 12/14/1994 | EP0627912A1 Gels for encapsulation of biological materials |
| 12/14/1994 | EP0627911A1 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
| 12/14/1994 | EP0101681B1 Antibody to a mediator activity composition and its use in a pharmaceutical composition |
| 12/14/1994 | CN1096289A Royal jelly strong active protein extracting method and products |
| 12/14/1994 | CN1096217A Traditional Chinese medicine beverage for prevention of cardiovascular and cerebrovascular disease |
| 12/14/1994 | CN1096203A Traditional Chinese medicine ointment for curing burns and preparing method |
| 12/14/1994 | CN1096201A Traditional Chinese medicine for curing gastric disease |
| 12/14/1994 | CN1096199A Fully-dissolving pearl powder and preparing process |
| 12/14/1994 | CN1096198A Powder medicine for curing fluorine-poisoning of domestic animals |
| 12/13/1994 | US5372821 Intestinal tissue of warm-blooded vertebrate; resistance to infection; healing bone fractures |
| 12/13/1994 | US5372810 Composition for the prevention and treatment of diarrhea in livestock |
| 12/13/1994 | CA1333471C Whey protein concentrate as food supplement |
| 12/09/1994 | CA2097949A1 Method for assessing the fertilization potential of mammalian spermatozoa and for inducing the acrosome reaction |
| 12/08/1994 | WO1994028425A1 Embryotoxic factors |
| 12/08/1994 | WO1994028153A2 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it |
| 12/08/1994 | WO1994028152A1 Defective adenoviruses and corresponding complementation lines |
| 12/08/1994 | WO1994028120A1 Process for the sterilization of biological compositions and the product produced thereby |
| 12/08/1994 | WO1994028113A1 Immortalization of denditric cells with v-myc oncogene |
| 12/08/1994 | WO1994027698A2 Continuous centrifugation process for the separation of biologic components from heterogeneous cell populations |
| 12/08/1994 | WO1994027633A1 Bandage for continuous application of biologicals |
| 12/08/1994 | WO1994027623A1 Anti-cholesterolemic egg, vaccine and method for production, and use |
| 12/08/1994 | WO1994027622A1 Surrogate tolerogenesis for the development of tolerance to xenografts |
| 12/08/1994 | WO1994027556A2 Animal model for hepatitis virus infection |
| 12/08/1994 | WO1994027426A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 12/08/1994 | CA2164102A1 Immortalization of denditric cells with v-myc oncogene |
| 12/08/1994 | CA2163737A1 Anti-cholesterolemic egg, vaccine and method for production and use |
| 12/08/1994 | CA2163450A1 Embryotoxic factors |
| 12/08/1994 | CA2140455A1 Continuous centrifugation process for the separation of biologic components from heterogeneous cell populations |
| 12/07/1994 | EP0627161A1 Use of L-carnitine and alkanoyl L-carnitines in the storage of blood for transfusions and stabilizing solutions containing them |
| 12/07/1994 | EP0605690A4 Povidone hydrogen peroxide preservation of blood, tissues and biological fluids. |
| 12/07/1994 | EP0322438B1 Purified follicle stimulating hormone |
| 12/07/1994 | EP0210189B1 Recombinant alveolar surfactant protein |
| 12/07/1994 | CN1096053A Preparation of low molecular weight hepatic cells growth hormone |
| 12/07/1994 | CN1095958A Dispensation of drug bag for curing disease of biliary and gastrointestinal tract and preparation thereof |
| 12/07/1994 | CN1095935A Chinese drug pill for treatment of cold |
| 12/07/1994 | CN1095929A Long-lived wine of cordyceps sinensis |
| 12/07/1994 | CN1095928A Nutrient liquor and preparation thereof |
| 12/07/1994 | CN1095927A Medicine for oxytocia and odinopoeia |
| 12/07/1994 | CN1095926A Multi-effect powder for curing carbuncle and furunculosis |
| 12/07/1994 | CN1095902A Cordyceps sinensis and donkey-hide gelatin nutrient liquor |
| 12/07/1994 | CN1026862C Process for producting of dry bioactive recombinant growth hormones |
| 12/06/1994 | US5371204 Interleukins |
| 12/06/1994 | US5371108 Tear film over ocular surface comprising layer of gel of oil and wax |
| 12/06/1994 | US5371073 Polypeptide factors from colostrum |
| 12/06/1994 | US5370869 Infusion into patient platelet concentrate that has been in contact with povidone-iodine or povidone-hydrogen peroxide or mixture to inactivate or destroy pathogenic microorganism |